News
Amylyx is a high-risk biotech targeting rare diseases with strong cash reserves. Key trials soon may drive a 40% stock upside.
8h
2UrbanGirls on MSNLos Angeles: The Silicon Valley of Gaming and Esports
Los Angeles has emerged as the undisputed capital of the gaming industry and esports world, transforming from the ...
The United States has brokered a ceasefire in Syria after Israel intervened in support of Druze communities who came under attack ...
Wichita State alumni team advances to TBT Sweet 16, but players voice frustration over dwindling attendance at Koch Arena.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results